These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 19383922)
1. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Kopetz S; Lesslie DP; Dallas NA; Park SI; Johnson M; Parikh NU; Kim MP; Abbruzzese JL; Ellis LM; Chandra J; Gallick GE Cancer Res; 2009 May; 69(9):3842-9. PubMed ID: 19383922 [TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells. Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327 [TBL] [Abstract][Full Text] [Related]
3. Targeting SRC in mucinous ovarian carcinoma. Matsuo K; Nishimura M; Bottsford-Miller JN; Huang J; Komurov K; Armaiz-Pena GN; Shahzad MM; Stone RL; Roh JW; Sanguino AM; Lu C; Im DD; Rosenshien NB; Sakakibara A; Nagano T; Yamasaki M; Enomoto T; Kimura T; Ram PT; Schmeler KM; Gallick GE; Wong KK; Frumovitz M; Sood AK Clin Cancer Res; 2011 Aug; 17(16):5367-78. PubMed ID: 21737505 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. Serrels A; Macpherson IR; Evans TR; Lee FY; Clark EA; Sansom OJ; Ashton GH; Frame MC; Brunton VG Mol Cancer Ther; 2006 Dec; 5(12):3014-22. PubMed ID: 17148760 [TBL] [Abstract][Full Text] [Related]
5. Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV Mol Cancer Ther; 2009 Nov; 8(11):3066-74. PubMed ID: 19861409 [TBL] [Abstract][Full Text] [Related]
6. Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src. Perez M; Lucena-Cacace A; Marín-Gómez LM; Padillo-Ruiz J; Robles-Frias MJ; Saez C; Garcia-Carbonero R; Carnero A Oncotarget; 2016 May; 7(22):33111-24. PubMed ID: 27105527 [TBL] [Abstract][Full Text] [Related]
7. Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Pichot CS; Hartig SM; Xia L; Arvanitis C; Monisvais D; Lee FY; Frost JA; Corey SJ Br J Cancer; 2009 Jul; 101(1):38-47. PubMed ID: 19513066 [TBL] [Abstract][Full Text] [Related]
8. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900 [TBL] [Abstract][Full Text] [Related]
9. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Konecny GE; Glas R; Dering J; Manivong K; Qi J; Finn RS; Yang GR; Hong KL; Ginther C; Winterhoff B; Gao G; Brugge J; Slamon DJ Br J Cancer; 2009 Nov; 101(10):1699-708. PubMed ID: 19861960 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer. Strickler JH; McCall S; Nixon AB; Brady JC; Pang H; Rushing C; Cohn A; Starodub A; Arrowood C; Haley S; Meadows KL; Morse MA; Uronis HE; Blobe GC; Hsu SD; Zafar SY; Hurwitz HI Invest New Drugs; 2014 Apr; 32(2):330-9. PubMed ID: 24173967 [TBL] [Abstract][Full Text] [Related]
12. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201 [TBL] [Abstract][Full Text] [Related]
13. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells. Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730 [TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer. Jia J; Starodub A; Cushman I; Liu Y; Marshall DJ; Hurwitz HI; Nixon AB Anticancer Drugs; 2013 Mar; 24(3):237-50. PubMed ID: 23275294 [TBL] [Abstract][Full Text] [Related]
15. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564 [TBL] [Abstract][Full Text] [Related]
16. Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo. Dai Y; Chen S; Shah R; Pei XY; Wang L; Almenara JA; Kramer LB; Dent P; Grant S Blood; 2011 Feb; 117(6):1947-57. PubMed ID: 21148814 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor. Luo FR; Barrett YC; Yang Z; Camuso A; McGlinchey K; Wen ML; Smykla R; Fager K; Wild R; Palme H; Galbraith S; Blackwood-Chirchir A; Lee FY Cancer Chemother Pharmacol; 2008 Nov; 62(6):1065-74. PubMed ID: 18301894 [TBL] [Abstract][Full Text] [Related]
19. Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma. Lue HW; Cole B; Rao SA; Podolak J; Van Gaest A; King C; Eide CA; Wilmot B; Xue C; Spellman PT; Heiser LM; Tyner JW; Thomas GV Oncotarget; 2015 Dec; 6(42):44675-87. PubMed ID: 26625308 [TBL] [Abstract][Full Text] [Related]
20. Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines. Premkumar DR; Jane EP; Pollack IF Int J Oncol; 2010 Sep; 37(3):633-43. PubMed ID: 20664932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]